Lion and The University Hospital Zurich explore development and commercialisation opportunities for Diamond-Hardness Nano-Carbon technology for heart valves and intrauterine contraceptives
London, 27 June 2023 – Lion Alternative Energy, a company dedicated to developing technologies that supports the planet and extends peoples’ lives, announces that it has signed a Memorandum of Understanding with The University Hospital Zurich in Switzerland.
Under the agreement Lion and The University Hospital Zurich will explore collaboration opportunities in the areas of development and commercialisation of Diamond-Hardness Nano Carbon technology for heart valves and intrauterine contraceptives for commercially viable markets.
Lion’s experimental data suggests that their nano-sized diamond-hard carbon coatings have higher bio-compatibility and better bio-integration with the surrounding connective tissue in the course of long-term encapsulation. The apparent lack of fibrous tissue formation with Lion’s nano-carbon coating technology will reduce a leading cause of implant failure
Commenting on the agreement, The University Hospital Zurich’s Director of Cardiac Surgery, Professor Omer Dzemali, said “A major concern in cardiovascular surgery is the risk of thromboses with stents or mechanical prostheses. With a diamond-hard nano-carbon coating we will not only extend durability of the prosthesis but reduce or even remove the need for anti-coagulant therapy. For stents, coating the external part of the stent will also strengthen the walls of vessels and inside the stent it will help maintain the blood liquid state.”
Professor Omer Dzemali noted, “if the technology works as we expect, then we can see the potential to develop our own heart values in cooperation with Lion and their other university partners like Imperial College of London”.
Mr. Kostas Liapis, Lion’s CEO and founder said, “Working with such a high-calibre institution will foster a positive environment for long term cooperation and innovation in nano-carbon coatings technology between leading Swiss and UK researchers and Lion’s Greek R&D Centre.”
Lion’s strategic goal is to position itself as a leader in the nano-carbon coating marketplace by developing a range of coating applications for industry.
For more information about Lion Alternative and its sustainable energy technologies, visit www.lionplc.com or contact Kostas Liapis, Executive Chairman, on +44 20 7060 5999 or +44 7503 100 999.
– END –
About Lion Alternative Energy plc
Lion Alternative Energy is a technology development company with offices in London, Athens and soon in Switzerland. Lion is a company dedicated to developing technologies that extend peoples’ lives and supports the transition to a sustainable, clean environment. Lion’s portfolio of technologies includes technologies addressing nano-carbon coatings for medical devices and implants, green hydrogen production, solar thermal, large-scale battery storage, materials recycling and SOx/NOx abatement. Lion is developing its technology in collaboration with Imperial College, London and University Hospital Zurich.
Contacts
Kostas Liapis Executive Chairman o: +44 20 7060 5999 m: +44 7503 100 999 e: kostas@lionplc.com
About The University Hospital Zurich
The University Hospital Zurich (USZ) is a Cantonal public university in Zurich.
USZ is at the forefront of research of the latest treatment methods and apply them according to strict scientific criteria. USZ are the sole provider of many therapies in Switzerland. Patients with complex and multiple health problems travel from all over the country and abroad to be treated at USZ. The percentage of patients with complex diseases is particularly high at the USZ.
Professor Omer Dzemali is USZ’s Director of the Clinic for Cardiac Surgery and Head of the Heart Alliance. Professor Dzemali specialises in research in Cardiothoracic Surgery. His most recent publication is ‘Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach’.
For further information:
Prof. Dr. med. Dr. h.c. Omer Dzemali
Chefarzt Klinik für Herzchirurgie
D +41 44 416 45 60
omer.dzemali@triemli.zuerich.ch